We are live on ! Find out more
IMMP

Immutep

6 hedge funds and large institutions have $354K invested in Immutep in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more capital invested

Capital invested by funds: $67K → $354K (+$287K)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

50% more funds holding

Funds holding: 46 (+2)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$10K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$147K +$135K +61,940 New
BFM
2
Boothbay Fund Management
New York
$134K +$123K +56,424 New
WPC
3
Waters Parkerson & Co
Louisiana
$48K
VWM
4
Valley Wealth Managers
New Jersey
$24K
TDC
5
Thompson Davis & Co
Virginia
$1K +$872 +400 New
UBS Group
6
UBS Group
Switzerland
-$10K -5,429 Closed

IMMP Hedge Fund Activity: Q2 2018 in Review

6 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2018, worth a combined $354K — up 428% from $67K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IMMP positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $135K. The largest seller was UBS Group, exiting entirely with an estimated $10K sold.

  • 6 institutional investors held Immutep (IMMP) as of Q2 2018, up from 4 in Q1 2018.
  • Funds reported $354K of Immutep stock for Q2 2018, up 428% quarter-over-quarter.
  • 3 funds opened new Immutep positions in Q2 2018 and 1 closed out, a net change of +2 holders.
  • The largest Immutep buyer in Q2 2018 was Morgan Stanley, an estimated $135K added.
  • The largest Immutep seller in Q2 2018 was UBS Group, an estimated $10K sold.

Based on aggregated 13F filings for Q2 2018.